3,375
Views
5
CrossRef citations to date
0
Altmetric
Psychiatrys

Long-term safety and efficacy, including anhedonia, of vortioxetine for major depressive disorder: findings from two open-label studies

ORCID Icon, , , &
Pages 613-619 | Received 20 Nov 2022, Accepted 05 Feb 2023, Published online: 08 Mar 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.